ARK Invest's 13F portfolio value increased by ~10% to ~$12B this quarter. Check out the top holdings and new stakes of the portfolio.

Feb. 4, 2025, Cathie Wood-led Ark Invest dumped $7.4 million worth of Palantir stock even as the shares rose 24% over 24-hours.

Ark Invest’s purchase of Iridium Communications Inc IRDM shares via ARK Space Exploration & Innovation ETF ARKX aligns with the company’s recent strong performance. On Monday, Ark picked up 22,067 Iridium shares worth $626,261.

CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneer in gene-editing technology, using its patented gene sequencing platform to produce precise cures for diseases that need DNA tampering. CASGEVY, the company’s flagship medication developed in collaboration with Vertex Pharmaceuticals, was one of the first gene-edited treatments on the market.

Legendary fund manager Cathie Wood isn’t typically associated with boring, dividend-paying companies. Known for picking up revolutionary firms such as Nvidia (NVDA), Tesla (TSLA) and Palantir (PLTR) on the cheap,